Research Article

An Add-On Treatment for Moderate COPD with Squill-Oxymel (a Traditional Formulation from Drimia maritima (L.) Stearn): A Pilot Randomized Triple-Blinded Placebo-Controlled Clinical Trial

Table 1

Characteristics of the study population by the groups.

VariablesSquill-Oxymel group (n = 21)Placebo group (n = 21)

Age (mean ± SD)60.00 ± 8.9961.10 ± 7.780.68
Sex, male, n (%)18 (47.4%)20 (52.6%)0.61